trelstar and Bone-Marrow-Diseases

trelstar has been researched along with Bone-Marrow-Diseases* in 1 studies

Other Studies

1 other study(ies) available for trelstar and Bone-Marrow-Diseases

Article	Year
Experimental protection by a luteinizing hormone-releasing hormone agonist of a bone marrow nitrosourea aplasia. Preliminary observations. Cancer letters, 1984, Volume: 25, Issue:2 D-Tryptophan-6-luteinizing hormone-releasing hormone (D-Trp6-LH-RH) applied from day -8 to day +15 before and after administration of the nitrosourea analog, N,N'-bis[N-(2-chloroethyl)-N-nitrosocarbamoyl]cysteamine (CNCC), favored bone marrow restoration, as independently evaluated by 3 observers in a double-blind fashion. Topics: Animals; Body Weight; Bone Marrow; Bone Marrow Diseases; Double-Blind Method; Gonadotropin-Releasing Hormone; Hematopoietic Stem Cells; Luteolytic Agents; Male; Mice; Nitrosourea Compounds; Triptorelin Pamoate	1984

Article

Year

Experimental protection by a luteinizing hormone-releasing hormone agonist of a bone marrow nitrosourea aplasia. Preliminary observations.

Cancer letters, 1984, Volume: 25, Issue:2

D-Tryptophan-6-luteinizing hormone-releasing hormone (D-Trp6-LH-RH) applied from day -8 to day +15 before and after administration of the nitrosourea analog, N,N'-bis[N-(2-chloroethyl)-N-nitrosocarbamoyl]cysteamine (CNCC), favored bone marrow restoration, as independently evaluated by 3 observers in a double-blind fashion.

Topics: Animals; Body Weight; Bone Marrow; Bone Marrow Diseases; Double-Blind Method; Gonadotropin-Releasing Hormone; Hematopoietic Stem Cells; Luteolytic Agents; Male; Mice; Nitrosourea Compounds; Triptorelin Pamoate

1984